302 related articles for article (PubMed ID: 27777925)
1. The Effect of Bariatric Surgery on the Spectrum of Fatty Liver Disease.
Nostedt JJ; Switzer NJ; Gill RS; Dang J; Birch DW; de Gara C; Bailey RJ; Karmali S
Can J Gastroenterol Hepatol; 2016; 2016():2059245. PubMed ID: 27777925
[TBL] [Abstract][Full Text] [Related]
2. The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome.
Aguilar-Olivos NE; Almeda-Valdes P; Aguilar-Salinas CA; Uribe M; Méndez-Sánchez N
Metabolism; 2016 Aug; 65(8):1196-207. PubMed ID: 26435078
[TBL] [Abstract][Full Text] [Related]
3. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
[TBL] [Abstract][Full Text] [Related]
4. Performance of the Bard Scoring System in Bariatric Surgery Patients with Nonalcoholic Fatty Liver Disease.
Nassif AT; Nagano TA; Okayama S; Nassif LS; Branco Filho A; Sampaio Neto J
Obes Surg; 2017 Feb; 27(2):394-398. PubMed ID: 27392972
[TBL] [Abstract][Full Text] [Related]
5. Improvement in nonalcoholic fatty liver disease and metabolic syndrome in adolescents undergoing bariatric surgery.
Loy JJ; Youn HA; Schwack B; Kurian M; Ren Fielding C; Fielding GA
Surg Obes Relat Dis; 2015; 11(2):442-9. PubMed ID: 25820083
[TBL] [Abstract][Full Text] [Related]
6. Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH?
Kohli R; Myronovych A; Tan BK; Salazar-Gonzalez RM; Miles L; Zhang W; Oehrle M; Sandoval DA; Ryan KK; Seeley RJ; Setchell KD
Dig Dis; 2015; 33(3):440-6. PubMed ID: 26045281
[TBL] [Abstract][Full Text] [Related]
7. Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease?
Haskins IN; Chang J; Nor Hanipah Z; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
Surg Obes Relat Dis; 2018 Mar; 14(3):342-346. PubMed ID: 29519663
[TBL] [Abstract][Full Text] [Related]
8. The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis.
Yeoh A; Wong R; Singal AK
Clin Liver Dis; 2023 May; 27(2):413-427. PubMed ID: 37024216
[TBL] [Abstract][Full Text] [Related]
9. Impacts of bariatric surgery on adverse liver outcomes: a systematic review and meta-analysis.
Wang G; Huang Y; Yang H; Lin H; Zhou S; Qian J
Surg Obes Relat Dis; 2023 Jul; 19(7):717-726. PubMed ID: 36890087
[TBL] [Abstract][Full Text] [Related]
10. The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Shouhed D; Steggerda J; Burch M; Noureddin M
Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):797-811. PubMed ID: 28712339
[TBL] [Abstract][Full Text] [Related]
11. Bariatric Surgery in NAFLD.
Chauhan M; Singh K; Thuluvath PJ
Dig Dis Sci; 2022 Feb; 67(2):408-422. PubMed ID: 34981313
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Metabolic Surgery on Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Clanton J; Subichin M
Surg Clin North Am; 2016 Aug; 96(4):703-15. PubMed ID: 27473796
[TBL] [Abstract][Full Text] [Related]
13. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
[TBL] [Abstract][Full Text] [Related]
14. Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement.
Nobili V; Vajro P; Dezsofi A; Fischler B; Hadzic N; Jahnel J; Lamireau T; McKiernan P; McLin V; Socha P; Tizzard S; Baumann U
J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):550-61. PubMed ID: 25591123
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review.
Cazzo E; Pareja JC; Chaim EA
Sao Paulo Med J; 2017; 135(3):277-295. PubMed ID: 28562737
[TBL] [Abstract][Full Text] [Related]
16. Bariatric Surgery is Effective and Safe for Obese Patients with Compensated Cirrhosis: A Systematic Review and Meta-Analysis.
Bai J; Jia Z; Chen Y; Li Y; Zheng S; Duan Z
World J Surg; 2022 May; 46(5):1122-1133. PubMed ID: 35275232
[TBL] [Abstract][Full Text] [Related]
17. Bariatric surgery and nonalcoholic fatty liver disease.
Bower G; Athanasiou T; Isla AM; Harling L; Li JV; Holmes E; Efthimiou E; Darzi A; Ashrafian H
Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):755-68. PubMed ID: 25919774
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous living donor liver transplant with sleeve gastrectomy for metabolic syndrome and NASH-related ESLD-First report from India.
Kumar S; Khandelwal N; Kumar A; Yadav K; Sharma S; Sable S; Chauhan A; Kapoor S; Varma V; Palep J; Kumaran V
Indian J Gastroenterol; 2017 May; 36(3):243-247. PubMed ID: 28560633
[TBL] [Abstract][Full Text] [Related]
19. Routine Liver Biopsy During Bariatric Surgery: an Analysis of Evidence Base.
Mahawar KK; Parmar C; Graham Y; Abouleid A; Carr WR; Jennings N; Schroeder N; Small PK
Obes Surg; 2016 Jan; 26(1):177-81. PubMed ID: 26428254
[TBL] [Abstract][Full Text] [Related]
20. Bariatric Surgery and Metabolic Dysfunction-Associated Fatty Liver Disease: a 2022 Update.
Lazaridis II; Delko T
Praxis (Bern 1994); 2023 Feb; 112(2):97-102. PubMed ID: 36722105
[No Abstract] [Full Text] [Related]
[Next] [New Search]
